This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Tuberculosis/ Other Mycobacterium  • Diagnosis  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2009;301(10):1014-1016.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2009;58:7-10

Guidelines for the use of nucleic acid amplification (NAA) tests for the diagnosis of tuberculosis (TB) were published in 1996¹ and updated in 2000.² Since then, NAA testing has become a routine procedure in many settings because NAA tests can reliably detect Mycobacterium tuberculosis bacteria in specimens 1 or more weeks earlier than culture.³ Earlier laboratory confirmation of TB can lead to earlier treatment initiation, improved patient outcomes, increased opportunities to interrupt transmission, and more effective public health interventions.^4-5 Because of the increasing use of NAA tests and the potential impact on patient care and public health, in June 2008, CDC and the Association of Public Health Laboratories (APHL) convened a panel of clinicians, laboratorians, and TB control officials to assess existing guidelines^1-2 and make recommendations for using NAA tests for laboratory confirmation of TB. On the basis of the panel's report and consultations with the Advisory Council . . . [Full Text of this Article]

Background



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?